![](https://investorshub.advfn.com/uicon/696413.png?cb=1554426698)
Saturday, January 26, 2019 4:22:52 PM
A merger with GenOne12 comes months after NutraNomics confirmed a strategic partnership with Tempus Biotechnologies. The partnership is for the development of improved products for the supplement market.
The company inked the strategic partnership in a bid to gain innovative expertise, necessary for improving its supplement formulations and delivery systems. Tempus Bio Technologies comes with experts in bio and Nanotechnology.
“This partnership expands us into smart, strategic alignments that are anticipating our services in not only CBD but also other plant-based ingredients, textiles, materials, ointments, and creams. We look forward to providing new and enhanced products that will be on the market in 2019,” states NutraNomics CEO and President, Jonathan Bishop.
https://insiderfinancial.com/nutranomics-inc-otcmktsnnrx-400-spike
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM